VPTDF (VentriPoint Diagnostics) Debt-to-Asset : 5.53 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is VentriPoint Diagnostics Debt-to-Asset?

VentriPoint Diagnostics VPTDF Debt-to-Asset is 5.53 as of Dec. 2025. The stock has 4 warning signs investors should review.

VentriPoint Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was $1.81 Mil. VentriPoint Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was $0.08 Mil. VentriPoint Diagnostics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2025 was $0.34 Mil. VentriPoint Diagnostics's debt to asset for the quarter that ended in Dec. 2025 was 5.53.

VentriPoint Diagnostics  (OTCPK:VPTDF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

VentriPoint Diagnostics Debt-to-Asset Related Terms

VentriPoint Diagnostics Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics Debt-to-Asset Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.08 0.22 2.48 5.53

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.48 2.40 4.20 6.22 5.53

VPTDF vs ABT, SYK, MDT: Debt-to-Asset Comparison

For the Medical Devices subindustry, VentriPoint Diagnostics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VentriPoint Diagnostics Debt-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Debt-to-Asset falls into.


VentriPoint Diagnostics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

VentriPoint Diagnostics's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.809 + 0.083) / 0.342
=5.53

VentriPoint Diagnostics's Debt-to-Asset for the quarter that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.809 + 0.083) / 0.342
=5.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 5.53 mean?
VentriPoint Diagnostics (VPTDF) has a Debt-to-Asset of 5.53 as of Dec. 2025. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on VentriPoint Diagnostics and its competitors.
Is VentriPoint Diagnostics' Debt-to-Asset too high?
VentriPoint Diagnostics' current Debt-to-Asset is 5.53.
How does VentriPoint Diagnostics' Debt-to-Asset compare to ABT and SYK?
VentriPoint Diagnostics' Debt-to-Asset of 5.53 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Medical Devices & Instruments company?
A good Debt-to-Asset depends on the Medical Devices & Instruments industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on VentriPoint Diagnostics and its competitors. VentriPoint Diagnostics's current Debt-to-Asset is 5.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VentriPoint Diagnostics stock overvalued right now?
VentriPoint Diagnostics (VPTDF) has a current Debt-to-Asset of 5.53. The current Debt-to-Asset is 5.53. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current Debt-to-Asset is 5.53 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VentriPoint Diagnostics Business Description

Other Exchanges VPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.